CTLA4 and neoplasm: In this study, using the Elastic Net Regression (ENLR) algorithm, we built an immunometabolism signature using on-treatment (IMME-ON) tumor specimens based on clinical information and transcriptome data from patients with metastatic melanoma after anti-PD1 and or anti-CTLA4 treatment.